1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Markets at a Glance: Pharmaceuticals

Markets at a Glance: Pharmaceuticals

  • May 2019
  • 115 pages
  • ID: 5777329
  • Format: PDF
  • By BCC Research

Summary

Table of Contents

Report Scope:
The “Market at a Glance Pharmaceuticals” provides a sampling of the market share in key therapeutics of pharmaceutical industry that has been aiding business decision making since the inception in 1971. It includes the market share and company profiles of leading players on the following markets -
- Active Pharmaceutical Ingredients: Global Markets to 2022 (PHM200A).
- Antipsychotic Drugs: Technologies and Global Markets (PHM063B).
- Brain Tumor Therapeutics: Global Markets to 2023 (PHM208A).
- Clinical Nutrition: Global Markets to 2022 (PHM198A).
- Diagnostics and Therapeutics for HIV: Global Markets (PHM058C).
- Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions (PHM177B).
- The Global Influenza Market (PHM049E).
- Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases (PHM005D).
- Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging (PHM043G).
- Global Markets for Infectious Disease Treatments (PHM061D).
- Neuroprotective Agents: Therapeutic Applications and Global Markets (PHM188A).

Report Includes:
- Examination of trends revolutionizing the pharmaceuticals sector
- An overview of Active Pharmaceutical Ingredients (API), antipsychotic drugs, and neuroprotective agents
- Information on Alnylam’s RNAi drug Onpattro, used to treat nerve damage from hereditary transthyretin-mediated amyloidosis
- Details pertaining to market share and company profiles of leading players of the industry

Summary
Advancement in science and technology has led to an exciting new era in therapeutics.The pharmaceutical industry is undergoing expansion, driven by the unmet needs in several diseases areas.

The growth is mainly driven by market expansion of leading players in emerging market and aging population which is augmenting the demand for novel therapeutics.

In a heavily disrupted marketplace, characterized by shifting payer attitudes and patient empowerment, neither incremental adjustments nor steady evolution are likely to halt the decline of the traditional pharmaceutical business model. This paper looks ahead to a 2030 scenario to examine the trends revolutionizing the sector; trends that we expect to have dramatic impacts.

The pharmaceutical industry is aimed towards innovative drug development with strong pipeline from leading global players. The pharmaceutical industry’s innovation soared in 2018 through approval of 64 novel drugs from U.S. FDA including Alnylam’s RNAi drug Onpattro to treat nerve damage from hereditary transthyretin-mediated amyloidosis, 17 drugs in oncology, and the CGRP migraine drugs from Teva Pharmaceutical, Eli Lilly and Co and Amgen.

The pharma industry is always in flux; however, the big pharmaceutical players retain their position near the near the top of yearly sales rankings. The 2018 was no different, with Johnson & Johnson, F Hoffmann-La Roche Ltd., Pfizer Inc., Novartis and Merck & Co. leading the industry with the top five spots by 2018 sales. The other leading players in pharmaceutical industry were GlaxoSmithKline Plc, Sanofi, AbbVie Inc., Bayer AG, Eli Lilly and Co., among others. The sales of new and existing drugs driven largely are focused on oncology, immunology and the nervous system.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($2500)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Endometriosis - Pipeline Review, H2 2019

Endometriosis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Endometriosis - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis - Pipeline Review, H2 2019, provides an overview of the Endometriosis (Women’s ...

Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019

Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019SummaryRetinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) pipeline Target constitutes close ...

Acromegaly - Pipeline Review, H2 2019

Acromegaly - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Acromegaly - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly - Pipeline Review, H2 2019, provides an overview of the Acromegaly (Hormonal Disorders) ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on